CSC partly reduces AKT and ERK signal transduction by releasing related extracellular vesicles or free tenascin C (TNC) to escape from anti-tumor T cells but induce tumor-promoting regulatory Tregs (184, 186). The gene discussed is AKT1; the disease is neoplasm.